Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10013145
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10013145
Fusion event
HBV-ANKRD52 integration
Validated
No
Detection method
NGS
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2018
PubMed ID
30271481
Virus Sequence
Virus name
HBV
Reference genome
NC_003977
Region type
S protein|Polymerase|large S protein|middle S protein|
Start
497
Orient
+
Integrated sequence
TCATCTTCCTCTTCATCCTGCTGCTATGCCTCATCTTCTTGTTGGTTCTTCTGGACTATCAAGGTATGTTGCCCGTTTGTCCTCTAATTCCAGGATCCTC| |AACAACCAGCACGGGACCATGCCGGACCTGCATGACTACTGCTCAAGGAACCTCTATGTATCCCTCCTGTTGCTGTACCAAACCTTCGGACGGAAATTGC
Host Sequence
Chromosome
chr12
Cytoband
q13.3
Reference genome
GRCh37/hg19
Start
56638886/56245102 (Hg38)
End
56638886/56245102 (Hg38)
Orient
+
Location type
splicing
Target gene
ANKRD52
miRNAs that regulate target gene
hsa-mir-130b-3p
;
hsa-mir-93-5p
;
hsa-mir-19b-3p
;
hsa-mir-877-3p
;
hsa-mir-744-5p
;
hsa-mir-766-3p
;
hsa-mir-92b-3p
;
hsa-mir-339-5p
;
hsa-mir-331-3p
;
hsa-mir-320a
;
hsa-mir-27b-3p
;
hsa-let-7b-5p
;
hsa-mir-543
;
hsa-mir-26a-5p
;
hsa-mir-26b-5p
;
hsa-mir-4723-5p
;
hsa-mir-5698
;
hsa-mir-6762-5p
;
hsa-mir-6825-5p
;
hsa-mir-6845-5p
;
hsa-mir-6870-5p
;
hsa-mir-7111-5p
;
hsa-mir-3127-3p
;
hsa-mir-6756-3p
;
hsa-mir-493-5p
;
hsa-mir-218-5p
;
hsa-mir-20a-5p
;
hsa-mir-106b-5p
;
hsa-mir-6715b-3p
;
hsa-mir-296-3p
;
hsa-mir-7844-5p
;
hsa-mir-6821-5p
;
hsa-mir-4278
;
hsa-mir-6789-5p
;
hsa-mir-4726-5p
;
hsa-mir-4640-5p
;
hsa-mir-6853-5p
;
hsa-mir-4755-3p
;
hsa-mir-6813-5p
;
hsa-mir-6085
;
hsa-mir-4688
;
hsa-mir-6743-5p
;
hsa-mir-4796-3p
;
hsa-mir-3609
;
hsa-mir-548ah-5p
;
hsa-mir-20b-5p
;
hsa-mir-17-5p
;
hsa-mir-106a-5p
;
hsa-mir-526b-3p
;
hsa-mir-519d-3p
;
hsa-mir-6787-5p
;
hsa-mir-663a
;
hsa-mir-1908-5p
;
hsa-mir-7702
;
hsa-mir-3157-3p
;
hsa-mir-4279
;
hsa-mir-151a-3p
;
hsa-mir-18b-3p
;
hsa-mir-5009-3p
;
hsa-mir-371b-3p
;
hsa-mir-33a-3p
;
hsa-mir-629-3p
;
hsa-mir-6867-3p
;
hsa-mir-4713-5p
;
hsa-mir-6720-5p
;
hsa-mir-6512-3p
;
hsa-mir-2682-3p
;
hsa-mir-6781-3p
;
hsa-mir-5088-3p
;
hsa-mir-6849-3p
;
hsa-mir-6819-3p
;
hsa-mir-6877-3p
;
hsa-mir-1233-5p
;
hsa-mir-1249-5p
;
hsa-mir-1321
;
hsa-mir-149-3p
;
hsa-mir-1827
;
hsa-mir-3154
;
hsa-mir-31-5p
;
hsa-mir-3184-5p
;
hsa-mir-3185
;
hsa-mir-3612
;
hsa-mir-3689d
;
hsa-mir-3911
;
hsa-mir-423-5p
;
hsa-mir-4271
;
hsa-mir-4300
;
hsa-mir-4419a
;
hsa-mir-4434
;
hsa-mir-4462
;
hsa-mir-4510
;
hsa-mir-4516
;
hsa-mir-4531
;
hsa-mir-4725-3p
;
hsa-mir-4728-5p
;
hsa-mir-4739
;
hsa-mir-4747-5p
;
hsa-mir-4756-5p
;
hsa-mir-4781-5p
;
hsa-mir-5196-5p
;
hsa-mir-541-3p
;
hsa-mir-5586-3p
;
hsa-mir-5591-5p
;
hsa-mir-5703
;
hsa-mir-6090
;
hsa-mir-6127
;
hsa-mir-6129
;
hsa-mir-6130
;
hsa-mir-6133
;
hsa-mir-6134
;
hsa-mir-625-5p
;
hsa-mir-650
;
hsa-mir-6515-5p
;
hsa-mir-654-5p
;
hsa-mir-658
;
hsa-mir-6726-5p
;
hsa-mir-6770-5p
;
hsa-mir-6778-5p
;
hsa-mir-6780b-5p
;
hsa-mir-6785-5p
;
hsa-mir-6797-5p
;
hsa-mir-6799-5p
;
hsa-mir-6827-5p
;
hsa-mir-6851-5p
;
hsa-mir-6880-5p
;
hsa-mir-6883-5p
;
hsa-mir-7515
;
hsa-mir-759
;
hsa-mir-7846-3p
;
hsa-mir-7847-3p
;
hsa-mir-885-3p
;
hsa-mir-920
;
hsa-mir-9500
Nearest miRNA
hsa-mir-1244-3/Upstream/1907788; hsa-let-7i/Downstream/949402;
Nearest TSS
ENST00000382841/Upstream/375;
ENST00000551566/Downstream/9982;
Nearest CpG islands
None/Target,
chr12-CpG: 104/Upstream/20512
,
chr12-CpG: 74/Downstream/12806
Upstream sequence
GAGGAGGGGTCATCAGGAAGGACAAGGGAAGTAGACTACCTGTCCTAAGCTCAAGTCATGGGCCCTCGCGAGAAGGGCTGATGCAGCAGAAGGGACTTAC
Downstream sequence
ACTGCACAGTGCAAAGGAGTGAAGGGGTTTCCTTCCAGGTACGAAAACGGGCTGTGTTCAAGTAACAACTCCAGACAATCTTCATGTCCTGGGCACGAGG
Reference
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.
Sample Information
×
Sample name
813Ca
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate